Kiora Pharmaceuticals
KPRX
10 hedge funds and large institutions have $9.39M invested in Kiora Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0.12% → 0.12% (+0%)
7% less capital invested
Capital invested by funds: $10.1M → $9.39M (-$713K)
17% less funds holding
Funds holding: 12 → 10 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$60K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.63K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.88K |
| 4 |
Renaissance Technologies
New York
|
+$1.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSWM
Golden State Wealth Management
Santa Ana,
California
|
-$9K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$8K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$4K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $8.73M | – | – | – |
|
|
2
Renaissance Technologies
New York
| $267K | +$1.88K | +1 | +0.7% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $168K | +$1.88K | +1 | +1% |
|
4
BlackRock
New York
| $126K | – | – | – |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $56K | +$60K | +32 | New |
|
6
US Bancorp
Minneapolis,
Minnesota
| $13K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $12K | +$5.63K | +3 | +75% |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $8K | – | – | – |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| $2K | -$1.88K | -1 | -50% |
|
10
Morgan Stanley
New York
| $2K | – | – | – |
|
|
GSWM
11
Golden State Wealth Management
Santa Ana,
California
| – | -$9K | -5 | Closed |
|
|
12
Victory Capital Management
San Antonio,
Texas
| – | -$8K | -4 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$4K | -2 | Closed |
|
KPRX Hedge Fund Activity: Q2 2020 in Review
10 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Kiora Pharmaceuticals (KPRX) for Q2 2020, worth a combined $9.39M — down 7.1% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of KPRX and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, opening a new position worth an estimated $60K. The largest seller was Golden State Wealth Management, exiting entirely with an estimated $9K sold.
- 10 institutional investors held Kiora Pharmaceuticals (KPRX) as of Q2 2020, down from 12 in Q1 2020.
- Funds reported $9.39M of Kiora Pharmaceuticals stock for Q2 2020, down 7.1% quarter-over-quarter.
- 1 fund opened new Kiora Pharmaceuticals positions in Q2 2020 and 3 closed out, a net change of -2 holders.
- The largest Kiora Pharmaceuticals buyer in Q2 2020 was Vanguard Group, an estimated $60K added.
- The largest Kiora Pharmaceuticals seller in Q2 2020 was Golden State Wealth Management, an estimated $9K sold.
Based on aggregated 13F filings for Q2 2020.